Formulations containing ester compounds and methods of making and using thereof
Ester compounds in formulations provide safe and effective insect repellency and enhanced drug absorption, addressing the limitations of DEET by offering prolonged protection and improved safety.
Patent Information
- Application Number
- PCT/US2026/027012
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-07
- Filing Date
- 2026-05-07
- Publication Date
- 2026-11-12
AI Technical Summary
Existing insect repellents like DEET are effective but pose health risks, have unpleasant odors, and damage materials, necessitating a need for safer and more effective alternatives.
Development of ester compounds in formulations that form emulsions, including cosmetically acceptable carriers, providing insect repellent effects lasting at least 12 hours and enhancing drug absorption through the skin.
The ester compounds offer long-lasting insect repellency and improved drug absorption, while being safe for human use and environmentally friendly.
Smart Images

Figure US2026027012_12112026_PF_FP_ABST
Abstract
Description
[0001] FORMULATIONS CONTAINING ESTER COMPOUNDS AND METHODS OF MAKING AND USING THEREOF
[0002] CROSS REFERENCE TO RELATED APPLICATION
[0003] This application claims priority to U.S. Provisional Patent Application No. 63 / 801,433, filed May 7, 2025, the disclosure of which is incorporated herein by reference.
[0004] FIELD OF THE INVENTION
[0005] The disclosed invention is generally in the field formulations including ester compounds and methods of making and using thereof, such as for insect or arachnid repellent applications.
[0006] STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
[0007] This invention was made with government support under DC007864 and AI165575 awarded by the National Institutes of Health. The government has certain rights in the invention.
[0008] BACKGROUND OF THE INVENTION
[0009] Mosquito-borne diseases continue to be a significant threat to global health and the critical need for effective and safe insect repellents has been increasing. Mosquitoes and other biting insects are vectors for severe illnesses such as malaria, dengue fever, Zika virus, and West Nile virus, affecting millions of people worldwide. Traditional repellents like DEET (A / N-diethyl-meta-toluamide) have been the cornerstone of personal protection since their introduction in the mid-20th century. While DEET is effective, it poses several drawbacks, including potential health risks, unpleasant odors, environmental concerns, and damage to certain materials like plastics and synthetic fabrics. In response to these challenges, there is a growing demand for insect repellents that are not only effective but also safe for people and the environment.
[0010] Accordingly, there remains a need for compounds and formulations thereof for providing improved insect repellents.
[0011] 1
[0012] 45853111.1Therefore, it is an object of the present invention to provide compounds for improved insect and / or arachnid repellent formulations.
[0013] It is a further object of the present invention to provide improved insect and / or arachnid repellent formulations.
[0014] It is a further object of the present invention to provide methods of preparing such formulations.
[0015] It is yet a further object of the present invention to provide methods of using such formulations.
[0016] SUMMARY OF THE INVENTION
[0017] Ester compounds, which can form part of formulations and can be used in various applications, such as to repel insects, are described herein. In some instances, such ester compounds have a structure according to Formula I:
[0018] 0 R2
[0019] R1^O^YO''R3
[0020]
[0021] o
[0022] Formula I
[0023] wherein Ri, R2, and R3 is a C1-C30 alkyl, C2-C30 alkenyl, or C2-C30 alkynyl, as well as individual values or sub-ranges of the aforementioned ranges.
[0024] In some instances, compounds of Formula I are able to form emulsions. An exemplary emulsion includes:
[0025] (i) one or more cosmetically acceptable carriers: and
[0026] (ii) one or more ester compounds of Formula I.
[0027] wherein the one or more cosmetically acceptable carriers are optionally impermeable or substantially skin impermeable.
[0028] Topical formulations containing a cosmetically acceptable carrier and an ester compounds according to Formula I are also disclosed herein. For instance, a topical formulation can include:
[0029] (i) one or more cosmetically acceptable carriers; and
[0030] (ii) one or more ester compounds of Formula I.
[0031] Such topical formulations can form various particular types of formulations, including insect repellent formulations and arachnid repellent formulations.
[0032] 2
[0033] 45853111.1In some instances, the topical formulation is an insect repellent formulation and at least the one or more ester compound provides an insect repellent effect. In some instances, such insect repellent formulations can repel mosquito bites for at least about 10, 11, or 12 hours, and optionally longer than 12 hours. Typically, the formulations can repel mosquito bites for at least about 12 hours, for greater than about 12 hours, or for 12 hours or longer. In one non- limiting instance, a method of repelling an insect or an arachnid, includes the steps of:
[0034] (a) applying a topical formulation as disclosed above to at least a portion of a skin surface of a subject;
[0035] wherein following step (a), the portion of the skin surface to which the topical formulation was applied provides a complete protection time of at least about 9 hours, optionally at least about 10 hours. The topical formulation is an insect repellent formulation.
[0036] In some other instances, the topical formulations can be or form part of a cosmetic formulation or personal care product. Thus, in some instances, such personal care products can be used in a method of treating skin, that involves:
[0037] (a’) applying any one of the topical formulations disclosed herein to at least a portion of a skin surface of a subject.
[0038] In yet other instances, pharmaceutical formulations containing an ester compound according to Formula I are possible. For example, a pharmaceutical formulation for delivering a drug agent via skin absorption can include:
[0039] one or more ester compounds of Formula I; and
[0040] at least one drug agent;
[0041] optionally further comprising one or more pharmaceutically acceptable excipients and / or carriers;
[0042] wherein the ester compound enhances absorption of the at least one drug agent through skin, as compared to a pharmaceutical formulation excluding the ester compound. In some instances, such pharmaceutical formulations can be used in a method of delivering a drug agent via skin absorption, involving (a”) applying any one of the pharmaceutical formulations disclosed herein to at least a portion of a skin surface of a subject; wherein skin absorption of the at least one drug agent through the skin surface of the subject is enhanced, as compared to skin absorption of the at least one drug agent applied alone to the skin surface.
[0043] 3
[0044] 45853111.1In still other instances, food-grade formulations, industrial formulations, and biobased plastics or resins, each independently containing an ester compound according to Formula I are also possible.
[0045] BRIEF DESCRIPTION OF THE DRAWINGS FIG.1 is a bar graph of the wildtype single choice artificial blood feeder assay of the compound ethyl lactate laurate comparing percent blood feed (y-axis) as a function of different ethyl lactate laurate concentrations (x-axis) applied onto artificial skin (membrane) from solution: 0% (control; ethanol alone) and 5%, 10%, 15%, and 20% vol% ethanolic solution.
[0046] DETAILED DESCRIPTION OF THE INVENTION
[0047] I. Definitions
[0048] “Generally regarded as safe for topical application to skin,” as used herein refers to substances that are considered safe for use in cosmetic products which are applied to the skin of a mammalian subject, such as a human. Such substances are generally understood in the field of cosmetics to be safe under the conditions of their intended use. In some instances, such substances may be reviewed by the Cosmetics Ingredient Review (CIR) and deemed safe for personal skincare products and categorized as safe to use, at specified concentrations, as may be applicable. See, for example: On-Line INFOBASE - ingredients - regulations - labeling - cosmetics - personal care products. International Journal of Toxicology 17(Suppl. 1): 1-3, 199s Copyright 1998 Cosmetic Ingredient Review, 1-3 (1998).
[0049] “Complete Protection l ime,” or “CPI’,” as used herein refers to the duration of time during which a repellent provides an effective defense against landing, biting, and / or contact of an insect species on an area or surface, such as when applied to skin, clothing, or other surfaces. The effectiveness of a repellent can be measured by its ability to provide protection for a specific period and indicates how long the repellent can effectively prevent landing, biting, and / or contact by the insect species with the treated area. For example, CPT can be calculated from the time between repellent application to the exposed skin and insertion into the cage and the first confirmed mosquito bite. A mosquito bite can be confirmed when after the bite occurs a second bite occurs within 30 minutes of the first bite. If a second bite does not occur within 30 minutes of the first 4
[0050] 45853111.1bite, then the first bite is not a “confirmed mosquito bite’’ and is dismissed, and the volunteer continues testing. Subsequently, if the volunteer receives another bite at any point of the testing, this subsequent bite is considered the first bite and they leave their arm in the cage for up to at least 30 minutes or until a confirmation bite is recorded (if it occurs in less than 30 minutes) to determine if the subsequent bite is confirmed. The test continues until a set time period is reached without a confirmed bite or until the first confirmed bite is achieved. See, e.g. Luker, et al. 2023. Sci Rep 13, 1705.
[0051] “Repellency,” as used herein is a measurement of the ability of a repellent to repel an insect or an arachnid, expressed as a percentage. Repellency (R%) is calculated using the formula:
[0052] ( T\
[0053] R(° / o) = C x 100%
[0054]
[0055] where C is the number of insect (such as mosquito) or arachnid bites on a control and T is the number of insect or arachnid bites on a repellent treated equivalent of the control. For example, an area of skin without any treatment may serve as a control (C) and the same area of skin treated with a repellent formulation may serve as treated (T). See Schreck C. E. Techniques for evaluation of insect repellents: a critical review. Annual Review of Entomology. 1977:22:101-119.
[0056] “Alkyl lactate,” as used herein refers to a chemical compound derived from lactic acid, which is a naturally occurring organic acid. In the context of alkyl lactates, the term "alkyl" refers to a hydrocarbon chain, which can vary in length.
[0057] “Fatty Acid,” as used herein refers to a chemical compound that consists of a hydrocarbon chain and a carboxylic acid group (-COOH) at one end. The hydrocarbon chain may be saturated (with hydrogen atoms on the hydrocarbon chain) or unsaturated (having one or more carbon-carbon double bonds in the hydrocarbon chain).
[0058] “Hydrophilic,” as used herein refers to substances, molecules, and agents having an affinity for and demonstrating solubility or dispersibility in water, facilitated by interactions such as hydrogen bonding and electrostatic attractions between the molecules and water molecules.
[0059] "Lipophilic," as used herein refers to substances, molecules, and agents that have an affinity for, or a tendency to dissolve in, lipids or fats. Such substances, molecules, and agents typically exhibit little to no solubility in water due to their non-polar nature.
[0060] 5
[0061] 45853111.1“Amphiphilic,” as used herein refers to substances, molecules, and agents that have both hydrophilic (water-attracting) and hydrophobic (water-repelling) parts or regions on the same substances, molecules, and agents.
[0062] "Alkyl", as used herein, refer to saturated or unsaturated aliphatic groups, including substituted or unsubstituted straight-chain alkyl groups, substituted or unsubstituted branched-chain alkyl groups, substituted or unsubstituted cycloalkyl. Unless otherwise indicated, a straight chain or branched chain alkyl has 30 or fewer carbon atoms in its backbone (e.g., C1-C30 for straight chain, C3-C30 for branched chain), more preferably 20 or fewer carbon atoms, more preferably 12 or fewer carbon atoms, and most preferably 8 or fewer carbon atoms. In some embodiments, the chain has 1-6 carbons. "Cycloalkyl" refers to a carbocyclic radical with a single ring (e.g., cyclohexyl), multiple rings (e.g., bicyclohexyl), or multiple fused rings. The cycloalkyl group may also have one or more double bonds. Likewise, preferred cycloalkyls have from 3-10 carbon atoms in their ring structure, and more preferably have 5, 6 or 7 carbons in the ring structure. The ranges provided above are inclusive of all values between the minimum value and the maximum value. The term "alkyl" includes both "unsubstituted alkyls" and "substituted alkyls", the latter of which refers to alkyl moieties having one or more substituents replacing a hydrogen on one or more carbons of the hydrocarbon backbone.
[0063] Unless the number of carbons is otherwise specified, "lower alkyl" as used herein refers to a straight or branched hydrocarbon radical with 1 to 6 carbon atoms, preferably 1 to 3 carbon atoms. Examples include but are not limited to, methyl, ethyl, propyl, isopropyl, n-butyl, sec -butyl, tert-butyl, pentyl, 2-pentyl, isopentyl, neopentyl, hexyl, 2-hexyl, 3-hexyl, and 3-methylpentyL
[0064] "Alkenyl" and "Alkynyl", as used herein, refer to unsaturated aliphatic groups containing one or more double or triple bonds, respectively, analogous in length (e.g., C2-C30) and possible substitution to the aliphatic groups described above. Unless the number of carbons is otherwise specified, "lower alkenyl" as used herein refers to a straight or branched hydrocarbon radical containing 2 to 6 carbon atoms and one or two double bonds, including, but not limited to, ethenyl, propenyl, l-but-3-enyl, l-pent-3-enyl, and l-hex-5-enyl. The alkenyl group can also be optionally mono-, di-, or trisubstituted with halo, aryl, cycloalkyl, or alkoxy. Unless the number of carbons is otherwise specified, "lower alkynyl" as used herein refers to a straight or branched 6
[0065] 45853111.1hydrocarbon radical containing 2 to 6 carbon atoms and one or two triple bonds, including, but not limited to, propynyl, l-but-3-ynyl, etc. The terms “alkenyl" and "alkynyl" includes both unsubstituted and substituted versions thereof, the latter of which refers to alkenyl or alkynyl moieties having one or more substituents replacing a hydrogen on one or more carbons of the hydrocarbon backbone.
[0066] The term “substituted,” as used herein, refers to all permissible substituents of the compounds or functional groups described. Exemplary substituents include, but are not limited to, halogens, hydroxyl groups, or any other organic groupings containing any number of carbon atoms, preferably 1-14 carbon atoms, and optionally include one or more heteroatoms, such as oxygen, sulfur, or nitrogen grouping in linear, branched, or cyclic structural formats. Representative substituents can include alkyl, substituted alkyl (such as -CF and -CD3), alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, halo, hydroxyl, alkoxy, formyl, substituted alkoxy, phenoxy, substituted phenoxy, aroxy, substituted aroxy, thio (-SH), substituted thio, arylthio, substituted arylthio, cyano, isocyano, substituted isocyano, carbonyl, substituted carbonyl, carboxyl, substituted carboxyl, carboxylates, amino, substituted amino, amide, substituted amide, sulfonyl, substituted sulfonyl, sulfonic acid, phosphoryl, substituted phosphoryl, phosphonyl, substituted phosphonyl, polyaryl, substituted polyaryl, cyclic (such as C3-C20 cyclic), substituted cyclic (such as substituted C3-C20 cyclic), heterocyclic, substituted heterocyclic, deuterium, trihaloalkyl (trifluoromethyl), unsubstituted diarylamino, substituted diarylamino, unsubstituted dialkylamino, substituted dialkylamino, azo, carbonate ester, nitro, nitroso, phosphino, pyridyl, NRR', SR, C(O)R, COOR, C(O)NR, SOR, and SOR groups, wherein R and R' are independently selected from hydrogen atom, deuterium atom, or any of the substituents named above.
[0067] Numerical ranges disclosed herein include, but are not limited to, ranges of temperatures, ranges of concentrations, ranges of bites, ranges of times, amongst other ranges disclosed below. The disclosed ranges, disclose individually each possible number that such a range could reasonably encompass, as well as any sub-ranges and combinations of sub-ranges encompassed therein. For example, disclosure of a range of concentrations is intended to disclose individually every possible value that such a range could encompass, consistent with the disclosure herein. For example, a concentration range of about 5 wt% to 10 wt% also discloses each weight concentration within the 7
[0068] 45853111.1range individually (i.e., 5, 5.6, 6, 6.8, 7, 7.1, 8, 8.4, 9, 9.9, 10, 10.11 wt%, amongst others), as well as any sub-range contained therein (about 5 to 7.5 wt%).
[0069] Use of the term "about" is intended to describe values either above or below the stated value, which the term “about” modifies, in a range of approx. + / - 10%; in other instances, the values may range in value either above or below the stated value in a range of approx. + / - 5%. When the term "about" is used before a range of numbers (i.e., about 1 -5) or before a series of numbers (i.e., about 1 , 2, 3, 4, etc.) it is intended to modify both ends of the range of numbers and / or each of the numbers recited in the entire series, unless specified otherwise.
[0070] IL Ester Compounds and Formulations Thereof
[0071] Various ester compounds are described herein which can form part of formulations. Such compounds and the formulations formed therefrom can be used in various applications, such as insect or arachnid repellent formulations. The disclosed ester compound according to Formula I are useful for personal care products, pharmaceutical formulations, food-grade formulations, and industrial formulations, and components in bio-based plastics and resins, as described elsewhere herein.
[0072] A. Ester Compounds
[0073] Disclosed herein are ester compounds according to Formula I:
[0074] O R2
[0075] R / O^Y° R3
[0076]
[0077] o
[0078] Formula I
[0079] wherein Ri, R2, and R3 is a C1-C30 alkyl, C2-C30 alkenyl, or C2-C30 alkynyl, as well as individual values or sub-ranges of the aforementioned ranges. For example, “Ci-C30” discloses Ci, C2, ... C28, C29, and C30 individually, as well as sub-ranges such as C5-C7, C11-C17, and C13-C26. Such alkyl, alkenyl, and alkynyl groups, as may be present, may be substituted by one or more substituents. In some non-limiting instances, R2is a Ci alkyl, such as methyl, and R3 is a C2alkyl, such as ethyl.
[0080] 8
[0081] 45853111.1Exemplary ester compounds according to Formula I are shown below:
[0082]
[0083] 9
[0084] 45853111.1
[0085]
[0086] In one particular instance, the ester compound of Formula I has the following structure:
[0087]
[0088] B. Emulsions containing the Ester compound
[0089] In some instances, the compounds of Formula I are able to form emulsions. The inherent amphiphilic properties of such ester compounds can facilitate the formation of, for example, inverse emulsions. In one non- limiting instance, an emulsion includes:
[0090] (i) one or more cosmetically acceptable carriers; and
[0091] (ii) an ester compound of Formula I.
[0092] wherein the one or more cosmetically acceptable carriers are optionally impermeable or substantially skin impermeable.
[0093] Such emulsions can be formed in one or more cosmetically acceptable carriers, such as a base oil, that is typically impermeable or substantially skin impermeable. “Skin impermeable,” refers to the skin acting as a barrier blocking the passage, absorption, or entry of the base oil through the skin entirely. Skin impermeability is understood to be maintained by the outermost layer of the skin, known as the stratum comeum, which consists of dead skin cells and lipids that form a protective barrier. “Substantially skin 10
[0094] 45853111.1impermeable,” refers to the skin acting as a barrier blocking the nearly all passage, absorption, or entry of the base oil through the skin, where less than about 5%, 4%, 3%, 2%, 1%, 0.9%, 0.8%, 0.7%, 0.6%, 0.5%, 0.4%, 0.3%, 0.2%, 0.1%, or less by weight of the base oil applied to a skin surface is able to pass through skin.
[0095] In certain instances, the one or more cosmetically acceptable carriers at a concentration ranging from about 50 wt% to 95 wt% or about 70 wt% to 90 wt% of the total weight of the emulsion, or at any individual concentration values or sub- ranges contained within the aforementioned ranges.
[0096] In some instances, the one or more cosmetically acceptable carriers can be selected from a paraffin oil, natural waxes or oils, such as beeswax or carnauba wax, mineral oil, petroleum, silicone oil, or a combination thereof. In some forms, the silicone oil is a heavy silicone oil, such as cyclopentasiloxane, cyclohexasiloxane, and / or dimethiconol and blends thereof. In some instances, the one or more cosmetically acceptable carriers may be or include at least one alcohol, such as ethanol.
[0097] In some instances, the carrier is a paraffin oil that does not permeate skin, is stable and does not become rancid at standard ambient temperature and pressure (SATP) (i.e. 25 °C and 1 atm). In some instances, the paraffin oil is a light paraffin oil, a heavy paraffin oil, or a combination thereof. A “light paraffin oil” is a highly refined and purified paraffin oil having a viscosity of less than or equal to 0.86 g ml.1, such as in the range of between about 0.83 to less than or equal to about 0.86 g mL-1and is typically odorless. A “heavy paraffin oil” is a paraffin oil having a viscosity of greater than about 0.86 g mL1, such as in a range of greater than about 0.86 to about 0.89 g mL-1and typically has a slight odor.
[0098] In some instances, the ester compound according to Formula I is at a concentration ranging from about 5 wt% to 30 wt%, 5 wt% to 25 wt%, about 5 wt% to 20 wt%, or about 5 wt% to 15 wt% of the total weight of the emulsion, or at any individual concentration values or sub-ranges contained within the aforementioned ranges. In some instances, the ester compound according to Formula I is at a concentration ranging from about 5 vol% to 30 vol%, 5 vol% to 25 vol%, about 5 vol% to 20 vol% or about 5 vol% to 15 vol% of the total volume of the emulsion, or at any individual concentration values or sub-ranges contained within the aforementioned ranges.
[0099] 11
[0100] 45853111.1In some instances, the emulsions are inverse emulsions (also referred to as reverse emulsions). In some forms, the emulsions or inverse emulsions contain micelles or droplets that have an average diameter on the nanometer scale and range from about 10 to 500 nanometers, about 10 to 450 nanometers, about 10 to 400 nanometers, about 10 to 350 nanometers, about 10 to 300 nanometers, about 10 to 250 nanometers, about 10 to 200 nanometers, about 10 to 150 nanometers, about 10 to 100 nanometers, about 10 to 75 nanometers, about 10 to 50 nanometers, or about 10 to 25 nanometers in diameter, or any individual value or sub-range contained therein. Techniques for evaluating the size and diameters of micelles or droplets in an emulsion are known in the art.
[0101] In certain instances, the emulsions form a microemulsion having self-assembled inverted micelles therein. Microemulsions demonstrate thermodynamic stability and form spontaneously. In other words, the micelles contained therein self-assemble spontaneously. The viscosity of the microemulsion is dependent on the dispersion of the micelles and the base medium in which they are dispersed in, wherein the heavier the base oil, the more viscous the microemulsion. Microemulsions can be transparent, translucent, or milky in appearance depending on droplet size and concentration.
[0102] Microemulsions can be monodisperse or substantially monodisperse. “Monodisperse,” refers to microemulsions where the micelles or droplets have a uniform size distribution and “substantially monodisperse,” refers to microemulsions where the majority (i.e., 90% or greater) of the micelles or droplets have a uniform size distribution.
[0103] In certain instances, the emulsion is a microemulsion, where the average diameter of the micelles or droplets are typically on the nanometer scale and range from about 10 to 100 nanometers, 10 to 75 nanometers, about 10 to 50 nanometers, about 10 to 25 nanometers, about 10 to 20 nanometers, or any individual value or sub-range contained therein.
[0104] In certain other instances, the emulsion is a nanoemulsion. In contrast to microemulsions, nanoemulsions generally have higher dispersities than microemulsions and are typically not monodisperse. Nanoemulsions demonstrate kinetic stability and usually require steps, such as high shear mixing and / or sonication, for their formation. Nanoemulsions are prone to separation over time and surfactant(s) or emulsifying agent(s) can be used to stabilize them. Nanoemulsions can have a range of viscosities, from low to high, depending on formulation and concentration.
[0105] 12
[0106] 45853111.1For nanoemulsions, the average diameter of the micelles or droplets contained therein can be on the nanometer scale and may range from about 20 to 400 nanometers in diameter, about 50 to 400 nm, about 100 to 400 nm, about 100 to 350 nm, about 100 to 300 nm, about 100 to 250 nm, about 100 to 200 nm, about 100 to 150 nm, or about 100 to 125 nm, or any individual value or sub-range contained therein.
[0107] In some instances, the emulsion further includes one or more surfactants and / or emulsifying agents that are generally regarded as safe for topical application to skin, such as human skin, therein. In some instances, the one or more surfactants are nonionic surfactants and / or amphoteric surfactants. Suitable non-ionic surfactants include but are not limited to alcohol ethoxylates, fatty acid ethoxylates, alkyl phenol ethoxylate, monoalkonaolamide ethoxylates, sorbitan esters and their ethoxylated derivatives, ethoxylated fats and oils, amine ethoxylates, ethylene oxide-propylene oxide copolymers, glycol esters, glycerol and polyglycerol esters, sucrose esters mono and polysaccharides surfactants, such as alkyl polyglucosides alkyl alcohol ethoxylates, capped alkyl alcohol ethoxylates, fatty alcohol ethoxylate propoxylates, ethoxylated siloxane copolymers (PEG dimethicone) including alkyl capped, and PEG / PPG dimethicones, or combinations thereof. Exemplary sorbitan esters and their ethoxylated derivatives include, but are not limited to, sorbitan oleate, sorbitan stearate, polysorbate 80 (polyoxyethylene (80) sorbitan monooleate), polysorbate- 20 (polyoxyethylene sorbitan monolaurate), polysorbate-40, (polyoxyethylene sorbitan monopalmitate), polysorbate-60 (polyoxyethylene sorbitan monostearate), and polysorbate-80 (polyoxyethylene sorbitan monooleate), and combinations thereof.
[0108] Amphoteric surfactants can have anionic or cationic properties depending on the pH of the formulation. In some instances, the one or more surfactants are or include amphoteric surfactants, such as imidiazolines and imidiazoline derivatives, isethionates, betaine derivatives, amphoacetate derivatives, or propionates, or a combination thereof. For example, the one or more amphoteric surfactants can be a betaine derivative, such as cocamidopropyl betaine.
[0109] In some instances, the one or more surfactants in the emulsion include a non-ionic surfactant, such as polysorbate 20, polysorbate 80, sorbitan oleate, or sorbitan stearate and an amphoteric surfactant, such as cocamidopropyl betaine.
[0110] In certain instances, the emulsions are free or substantially free of any surfactants and / or emulsifying agents. “Substantially free,” as used herein refers to an emulsion 13
[0111] 45853111.1having less than about 3%, 2%, 1%, 0.0%, 0.8%, 0.7%, 0.6%, 0.5%, 0.4%, 0.3%, 0.2%, 0.1 %, or less by weight of the total weight of the emulsion.
[0112] In some instances, the emulsion can further include a cargo selected from insect repellent agents (such as DEET), sun blocking agents, antibacterial agents, skin repair agents, wound repair agents, and fragrances, or a combination thereof. In some instances, the cargo is hydrophilic. In some other instances, the cargo can be lipophilic and can be suspended in a continuous oil phase, such as formed by the base oil of the emulsion.
[0113] In certain instances, the emulsion includes one or more water-absorbing compounds to enhance stability, rheological properties, and / or overall functionality. In certain instances, the water-absorbing compounds are alginates, chitosan derivatives, carboxymethyl cellulose (CMC), polyacrylates, or other hydrocolloids. In some instances, the water- absorbing compound is CMC. In certain instances, the water absorbing compounds are incorporated into the emulsion at concentrations ranging from about 0.1 wt% to 5.0 wt%, about 0.1 wt% to 4.5 wt%, about 0.1 wt% to 4.0 wt%, about 0.1 wt% to 3.5 wt%, or about 0.1 wt% to 3.0 wt%, or individual values or sub-ranges of the aforementioned ranges, in order to help absorb water and maintain structural integrity in varying humidity conditions. The inclusion of one or more water-absorbing compounds, for example CMC, can reduce water mobility within the emulsion, thereby mitigating phase separation and preventing viscosity shifts of about 5% - 65%, 5% -60%, 5% - 55%, 5% - 50%, 10% - 50%, 15% - 50%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, or at least 50%, or more, or individual values or sub-ranges of the aforementioned ranges, from the baseline viscosity value under standard temperature and pressure (STP) conditions. The inclusion of waterabsorbing compounds can facilitate a uniform distribution of active components when the emulsion is stored or applied under conditions involving temperature which are below about 5 °C or above about 40°C, or humidity conditions which are below about 20% relative humidity (RH) or above about 80% RH.
[0114] In some instances, the emulsions may contain one or more stabilizers to improve the emulsion’s physical integrity and reduce phase separation. In certain instances, the stabilizer is glycerol oleate, a safe nonionic surfactant or co-emulsifier. Other suitable stabilizers are known. In certain instances, the one or more stabilizers are incorporated into the emulsion at concentrations ranging from about 0.1 wt% to 5.0 wt%, about 0.1 wt% to 4.5 wt%, about 0.1 wt% to 4.0 wt%, about 0.1 wt% to 3.5 wt%, or about 0.1 wt%
[0115] 14
[0116] 45853111.1to 3.0 wt%, or individual values or sub-ranges of the aforementioned ranges,. The stabilizers may help form a stabilized interface between the continuous (oil) and dispersed (micellar) phases. Such stabilizers enhance the long-term shelf life of the emulsion, particularly under elevated temperature or fluctuating humidity conditions.
[0117] In some instances, the emulsion may contain one or more antioxidants to reduce oxidative degradation of the emulsion over time. In some instances, the one or more antioxidants can include tocopherols and / or butylated hydroxytoluene (BHT). Other suitable antioxidants are known. In some instances, the one or more antioxidants are incorporated into the emulsion at concentrations ranging from about 0.05 wt% to 3.0 wt%, about 0.05 wt% to 2.5 wt%, about 0.05 wt% to 2.0 wt%, about 0.05 wt% to 1.5 wt%, or about 0.05 wt% to 1.0 wt%, or individual values or sub-ranges of the aforementioned ranges. The addition of antioxidants can extend the product’s shelf life, preserve product color and / or odor, and maintain the potency of lipophilic ingredients (e.g., fatty acids and base oils).
[0118] In certain instances, the emulsion contains one or more humectants to enhance user comfort by retaining moisture on the skin on which it is applied. In some instances, the one or more humectants can be glycerin and / or sorbitol. Other suitable humectants are known. In certain instances, the one or more humectants are added at concentrations between about 0.5 wt% to 7.0 wt%, about 0.5 wt% to 6.5 wt%, about 0.5 wt% to 6.0 wt%, about 0.5 wt% to 5.5 wt%, about 0.5 wt% to 5.0 wt%, about 0.2 wt% to 5 wt% or about 0.1 wt% to 5 wt%, or individual values or sub-ranges of the aforementioned ranges. The presence of humectants helps counteract dryness or irritation, improving the overall sensory attributes of the emulsion during topical application.
[0119] The emulsions described above can be used for various applications, such as insect or arachnid repellent formulations, amongst other uses described elsewhere for the formulations containing ester compounds of Formula I.
[0120] C. Topical Formulations containing the Ester Compounds Topical formulations containing a cosmetically acceptable carrier and an ester compound(s) according to Formula I are also disclosed herein. In one non-limiting instance, a topical formulation includes:
[0121] (i) one or more cosmetically acceptable carriers; and
[0122] (ii) one or more ester compounds of Formula I.
[0123] 15
[0124] 45853111.1In some instances, the cosmetically acceptable carrier is a base oil that is optionally impermeable or substantially skin impermeable.
[0125] In certain instances, the one or more cosmetically acceptable carriers are at a concentration ranging from about 50 wt% to 95 wt% or about 70 wt% to 90 wt% of the total weight of the topical formulation, or at any individual concentration values or subranges contained within the aforementioned ranges.
[0126] In some instances, the one or more cosmetically acceptable carrierscan be selected from a paraffin oil, natural waxes or oils, such as beeswax or carnauba wax, mineral oil, petroleum, and silicone oil, or a combination thereof. In some forms, the silicone oil is a heavy silicone oil, such as cyclopentasiloxane, cyclohexasiloxane, and / or dimethiconol and blends thereof. In some instances, the one or more cosmetically acceptable carriers are selected to be a paraffin oil that does not permeate skin, is stable and does not become rancid at standard ambient temperature and pressure (SATP) (i.e.
[0127] 25 °C and 1 atm). In some instances, the paraffin oil is a light paraffin oil, a heavy paraffin oil, or a combination thereof. A “light paraffin oil” is a highly refined and purified paraffin oil having a viscosity of less than or equal to 0.86 g mL"1, such as in the range of between about 0.83 to less than or equal to about 0.86 g mL-1and is typically odorless. A “heavy paraffin oil” is a paraffin oil having a viscosity of greater than about 0.86 g mL1, such as in a range of greater than about 0.86 to about 0.89 g ml.1and typically has a slight odor.
[0128] In some instances, the ester compound according to Formula I is at a concentration ranging from about 5 wt% to 30 wt%, 5 wt% to 25 wt%, about 5 wt% to 20 wt%, or about 5 wt% to 15 wt% of the total weight of the topical formulation, or at any individual concentration values or sub-ranges contained within the aforementioned ranges. In some instances, the ester compound according to Formula I is at a concentration ranging from about 5 vol% to 30 vol%, 5 vol% to 25 vol%, about 5 vol% to 20 vol% or about 5 vol% to 15 vol% of the total volume of the topical formulation, or at any individual concentration values or sub-ranges contained within the aforementioned ranges.
[0129] In some instances, the topical formulations further contain one or more cosmetically acceptable excipients. In some instances, the one or more cosmetically acceptable excipients are the topical formulation further comprises one or more cosmetically acceptable excipients selected from the group consisting of an abrasive, an 16
[0130] 45853111.1acidulent, an adhesion promoter, an antioxidant, an antiseptic, an astringent, a barrier agent, a bio-adhesive agent, a botanical agent, a botanical extract, a buffer agent, a bulking agent, a calming agent, a chelating agent, a cleansing agent, an emulsifier agent, a colorant, a conditioning agent, a cooling agent, a deodorant agent, a depilatory agent, a detergent, a disinfectant, a dispersant, an emollient, an emulsifier, an emulsion stabilizer, an essential oil, an exfoliant, a fat soluble agent, a fiber, a film former, a fixative, a foam booster, a foam stabilizer, a foaming agent, a fragrance, a free radical scavenger, a fungicide, a gellant, a glosser, a bleaching agent, a conditioning agent, a humectant, a lathering agent, a lubricant, a make-up agent, a moisture barrier agent, a moisturizing agent, a neutralizer, an odor-masking agent, an oil, an oil absorbent agent, an ointment base, an opacifier, an organosilicone, an oxidant, an oxygen carrier, a pearlant agent, a perfume, a perfume solvent, a perfume stabilizer, a peroxide stabilizer, a photo-sensitizer agent, a pigment, a pigmenting agent, a pearlescent aid, a plant extract, a plant derivative, a plant tissue extract, a plant root extract, a plant seed extract, a plant oil, a plasticizer, a polymer, a polymer film former, a preservative agent, a propellant, a reducing agent, a re-fatting agent, a resin, a scalp agent, a scrub agent, a sequestrant, a silicone agent, a skin clarifier, a skin cleanser, a skin lipid, a skin lightening agent, a skin bleaching agent, a solubilizer, a suspending agent, a sun protection agent, a soothing agent, a spreading agent, a stabilizer, a sunless tanning agent, a sunscreen, a sunscreen UVA, a sunscreen UVB, a broad-band sunscreen, a surfactant, an amphoteric surfactant, an anionic surfactant, a cationic surfactant, a non-ionic surfactant, a silicone surfactant, an accelerator, a thickening agent, a thixotrope, a tightening agent, a toner, a tonic agent, a vegetable oil, a volatile agent, a viscosity stabilizer, a vitamin, a water proofing agent, a wax, a wetting agent, a whitening agent, water, water-absorbing agents, dermatologically acceptable organic solvents, or a combinations thereof. In some instances, the one or more cosmetically acceptable excipients is at a concentration ranging from about 0.001 wt% to about 99 wt% of the total weight of the topical formulation. In some instances, the cosmetically acceptable carrier is at a concentration ranging from about 0.01 wt% to about 95 wt% of the total weight of the skin formulation Suitable non-ionic surfactants include but are not limited to alcohol ethoxylates, fatty acid ethoxylates, alkyl phenol ethoxylate, monoalkonaolamide ethoxylates, sorbitan esters and their ethoxylated derivatives, ethoxylated fats and oils, amine ethoxylates, ethylene oxide-propylene oxide co-polymers, glycol esters, glycerol and polyglycerol 17
[0131] 45853111.1esters, sucrose esters mono and polysaccharides surfactants, such as alkyl polyglucosides alkyl alcohol ethoxylates, capped alkyl alcohol ethoxylates, fatty alcohol ethoxylate propoxylates, ethoxylated siloxane copolymers (PEG dimethicone) including alkyl capped, and PEG / PPG dimethicones, or combinations thereof. Exemplary sorbitan esters and their ethoxylated derivatives include, but are not limited to, sorbitan oleate, sorbitan stearate, polysorbate 80 (polyoxyethylene (80) sorbitan monooleate), polysorbate-20 (polyoxyethylene sorbitan monolaurate), polysorbate-40, (polyoxyethylene sorbitan monopalmitate), polysorbate-60 (polyoxyethylene sorbitan monostearate), and polysorbate-80 (polyoxyethylene sorbitan monooleate), and combinations thereof.
[0132] Amphoteric surfactants can have anionic or cationic properties depending on the pH of the formulation. In some instances, the one or more surfactants are or include amphoteric surfactants, such as imidiazolines and imidiazoline derivatives, isethionates, betaine derivatives, amphoacetate derivatives, or propionates, or a combination thereof. For example, the one or more amphoteric surfactants can be a betaine derivative, such as cocamidopropyl betaine.
[0133] In some instances, the one or more surfactants in the emulsion include a nonionic surfactant, such as polysorbate 20, polysorbate 80, sorbitan oleate, or sorbitan stearate and an amphoteric surfactant, such as cocamidopropyl betaine. In certain instances, the topical formulations are free or substantially free of any surfactants and / or emulsifying agents. In certain instances, the surfactants are at a concentration ranging from about 0.1 wt% to about 30 wt%, 0.1 wt% to about 25 wt%, 0.1 wt % to about 20 wt%, 0.1 wt% to about 15wt%, or 0.1 wt% to about 10 wt% of the total weight of the topical formulation
[0134] In some instances, the antioxidants are optionally selected from tocopherol (Vitamin E), ascorbyl palmitate, butylated hydroxytoluene (BHT), and combinations thereof. Optionally, the antioxidants are at a concentration ranging from about 0.01 wt% to about 20 wt%, about 0.01% to about 15% wt%, about 0.01 wt% to about 10 wt%, about 0.01 wt% to about 7 wt%, about 0.01 wt% to about 5 wt% of the total weight of the topical formulation.
[0135] In some instances, the topical formulation further contains one or more additives. In some instances, the one or more additives are insect repellent agents, sun blocking agents, antibacterial agents, skin repair agents, wound repair agents, and fragrances, or a combination thereof.
[0136] 18
[0137] 45853111.1In some instances, the topical formulations are in the form of emulsions, such as inverse emulsions, microemulsions, or nanoemulsions.
[0138] The topical formulations described herein can form various particular types of formulations, as described below:
[0139] 1. Insect Repellent Formulations containing the Ester Compounds
[0140] In some instances, the topical formulation is an insect repellent formulation and at least the one or more ester compounds provide an insect repellent effect. In some instances, such insect repellent formulations can repel mosquito bites for at least about 10, 11, or 12 hours, and optionally longer than 12 hours. Typically, the formulations can repel mosquito bites for at least about 12 hours, for greater than about 12 hours, or for 12 hours or longer.
[0141] 2. Personal Care Product Formulations containing the Ester Compounds
[0142] In some other instances, the topical formulations can be or form part of a cosmetic formulation or personal care product and the ester compound acts, for example, as an emollient, a moisturizer, and / or a cosmetically acceptable carrier. In some instances, the personal care product is a lotion, a cream, a gel, or an ointment.
[0143] D. Pharmaceutical Formulations containing the Ester Compounds Pharmaceutical formulations containing an ester compound according to Formula I as described above, and at least one drug agent for delivering a drug agent are also disclosed herein. In one non- limiting instance, a pharmaceutical formulation for delivering a drug agent via skin absorption includes:
[0144] one or more ester compound of Formula I: and
[0145] at least one drug agent;
[0146] optionally further includes one or more pharmaceutically acceptable excipients and / or carriers:
[0147] wherein the ester compound enhances absorption of the at least one drug agent through skin, as compared to a pharmaceutical formulation excluding the ester compound.
[0148] The ester compound enhances absorption of the at least one drug agent through skin, as compared to a formulation excluding the ester compound. In some instances, the ester compound enhances the absorption of the at least one drug agent through skin by at 19
[0149] 45853111.1least about 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 100%, 105%, 110%, 115%, 120%, 125%, 130%, 135%, 140%, 145%, 150%, 155%, 160%, 165%, 170%, 175%, 180%, 185%, 190%, 195%, or 200%. In some instances, the absorption of the at least one drug agent is improved by an amount ranging from about 1% to 10%, 1% to 20%, 1% to 30%, 1% to 40%, 1% to 50%, 1% to 60%, 1% to 70%, 1% to 60%, 1% to 70%, 1% to 80%, 1% to 90%, 1% to 100%, 1% to 110%, 1% to 120%, 1% to 130%, 1% to 140%, 1% to 150%, 1% to 160%, 1% to 170%, 1% to 180%, 1% to 190%, or 1% to 200%, as compared to a formulation excluding the ester compound.
[0150] In some instances, the formulation contains ester compound(s) according to Formula I, together with one or more pharmaceutically acceptable carriers and / or excipients. Suitable pharmaceutically acceptable carriers and excipients are generally recognized as safe (GRAS), and may be administered to an individual without causing undesirable biological side effects or unwanted interactions.
[0151] Representative carriers and excipients include solvents (including buffers), diluents, pH modifying agents, preservatives, antioxidants, suspending agents, wetting agents, viscosity modifiers, tonicity agents, and stabilizing agents, and a combination thereof.
[0152] Excipients can be added to the pharmaceutical formulations to assist in sterility, stability (e.g. shelf-life), integration, and to adjust and / or maintain pH or isotonicity of the pharmaceutical formulation.
[0153] Without limitation, the at least one drug can be selected from therapeutic, prophylactic, and / or diagnostic agents. Non-limiting examples of therapeutic, prophylactic, or diagnostic agents can include bronchodilators, corticosteroids, methylxanthines, phosphodiesterase-4 inhibitors, anti-angiogenesis agents, antibiotics, antioxidants, anti-viral agents, anti-fungal agents, anti-inflammatory agents, immunosuppressant agents, anti-allergic agents, and combinations thereof. The amount of any additional therapeutic, prophylactic, or diagnostic agents generally depends on the severity of the diseases and / or disorders to be treated. Specific dosages can be readily determined by those of skill in the art. See Ansel, Howard C. et al., Pharmaceutical Dosage Forms and Drug Delivery Systems (6th ed.) Williams and Wilkins, Malvern, PA (1995).
[0154] 20
[0155] 45853111.1E. Food-Grade Formulations containing the Ester Compounds Food-grade formulations containing an ester compound according to Formula I as described above, and optionally one or more food-grade acceptable carriers are disclosed herein. “Food grade acceptable carriers’' refers to solvents or liquid carriers that are safe for use in food or food-related products and do not introduce harmful substances into food and are non-toxic or used at levels deemed safe for human consumption. Nonlimiting examples of include water , ethanol (specifically food-grade or beverage-grade ethanol), vegetable oils (like soybean oil, sunflower oil, medium-chain triglycerides (MCT oil)), glycerin (vegetable-derived, USP or food-grade), and / or propylene glycol (USP or food-grade only), and the like. The ester compound(s) in such food-grade formulations can act as a flavoring agent and / or a preservative therein. For example, the ester compound may add a particular flavor to the formulation, as compared to the same formulation in the absence of the ester compound. The ester compound may also act to increase the shelf-life and stability of the formulation, as compared to the same formulation in the absence of the ester compound.
[0156] F. Industrial Formulations containing the Ester Compounds Industrial formulations containing an ester compound according to Formula I as described above as a biodegradable solvent and / or as a lubricant are also disclosed. In some instances, the industrial formulation, further contains one or more carriers, such as an oil. In some instances, the industrial formulation further contains one or more additives. In some instances the one or more additives are corrosion inhibitors, pour point depressants, extreme pressure additives, anti-wear agents, metal deactivators, defoamer additives, penetrating lubricants, detergents, viscosity index improvers, dispersants, tackifiers, emulsifiers, friction modifiers, antioxidants, seal swell agents, or a combination thereof.
[0157] G. Bio-based Plastic or Resins
[0158] Bio-based plastics or resins including an ester compound according to Formula I as described above and / or a reaction product thereof are disclosed herein. In some instances, the bio-based plastic or resin further contains one or more additives selected from plasticizers, stabilizers, resins, fillers colorants, lubricants, or combinations thereof.
[0159] III. Methods of Preparing Compounds and Formulations Thereof Disclosed herein is a method of making an ester compound according to Formula I:
[0160] 21
[0161] 45853111.10 R2
[0162] R / O^ 'RS
[0163]
[0164] o
[0165] Formula I
[0166] wherein Ri, R2, and R3 is a C1-C30 alkyl, C2-C30 alkenyl, or C2-C30 alkynyl. In some instances, the ester compound according to Formula I can be prepared through direct esterification, transesterification, Steglich esterification, or N-(3-Dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC) esterification.
[0167] In some instances, direct esterification includes chemical esterification, heat esterification, or enzymatic esterification. In one non-limiting instance, the ester compound according to Formula I is prepared by chemical esterification with a C2-C30 alkyl lactate and a C2-C30 fatty acid as the reactants, wherein the reactants are heated under reflux conditions, with continuous removal of water to drive the reaction forward. The product is then purified by distillation or chromatography. In one non-limiting instance, the ester compound according to Formula I is prepared by enzymatic esterification with a C2-C30 alkyl lactate and a C2-C30 fatty acid as the reactants, wherein the reactants are mixed together with an lipases, such as Candida antarctica lipase B, under mild temperatures (30-60°C) and solvent-free or in organic solvents. In one nonlimiting instance, the ester compound according to Formula I is prepared by heat esterification with a C2-C30 alkyl lactate and a C2-C30 fatty acid as the reactants, wherein the reactants mixed together and molecular sieves (3A or 4A) are added to the mixture to absorb the water generated during the esterification reaction, which shifts the equilibrium toward ester formation. The mixture is then heated to approximately 120°C moisture free conditions. This temperature is maintained with continuous stirring for about 6 to 8 hours to allow the reaction to proceed efficiently without the need for catalysts or solvents. After the reaction is complete, the mixture is cooled to room temperature, and the molecular sieves and any unreacted solids are removed by filtration. The resulting ethyl lactate laurate is purified by washing with distilled water to remove impurities, drying over anhydrous sodium sulfate to eliminate residual moisture, and, if necessary, further purified by vacuum distillation or column chromatography to achieve the desired purity.
[0168] In some instances, transesterification includes chemical transesterification and enzymatic transesterification. In one non-limiting instance, the ester compound
[0169] 22
[0170] 45853111.1according to Formula I is prepared by chemical transesterification with a C2-C30 alkyl lactate and a C2-C30 methyl ester as the reactants, wherein the reactants are mixed and heated in the presence of a base catalyst, such as sodium methoxide, allowing the exchange of ester groups. In one non-limiting instance, the ester compound according to Formula I is prepared by enzymatic transesterification with a C2-C30 alkyl lactate and a C2-C30 activated ester, which is an ester compound wherein the ester functional group is susceptible toward nucleophilic attack such as a C2-C30 vinyl ester, as the reactants, wherein the reactants are mixed together in the presence of a lipases.
[0171] In one non- limiting instance, the ester compound according to Formula I is prepared by Steglich esterification with a C2-C30 alkyl lactate and a C2-C30 fatty acid as the reactants, wherein the reactants are mixed together in the presence of dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP) under mild conditions at room temperature, forming an active ester intermediate that reacts with ethyl lactate.
[0172] In one non-limiting instance, the ester compound according to Formula 1 is prepared by EDC esterification with a C2-C30 alkyl lactate and a C2-C30 fatty acid as the reactants, wherein the reactants are mixed together in the presence of hydrochloride (EDC) and 4-dimethylaminopyridine (DMAP). The reaction mixture is stirred continuously for 12-24 hours at room temperature under mild an anhydrous conditions. After completion, the reaction mixture is diluted with ethyl lactate and sequentially washed with water, saturated sodium bicarbonate solution, and brine to remove impurities and by-products. The organic layer is dried over anhydrous sodium sulfate, filtered to remove solids, and then concentrated under reduced pressure. Typically, the crude product obtained is around 85% purity without additional purification. If higher purity is desired, the product can be further purified using column chromatography with silica gel as the stationary phase and an appropriate solvent mixture (typically hexane / ethyl acetate) as the eluent.
[0173] Exemplary C2-C30 fatty acids include acetic acid, propionic acid, butyric acid, caproic acid, caprylic acid, capric acid, undecanoic acid, lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid, behenic acid, lignoceric acid, oleic acid, linoleic acid, linolenic acid, and arachidonic acid.
[0174] 23
[0175] 45853111.1Exemplary C2-C30 alkyl lactate include ethyl L lactate, methyl L lactate, propyl L lactate, butyl Llactate, pentyl L-lactate, hexyl L-lactate, heptyl L-lactate, isopropyl L- lactate, ethylhexyl L lactate, and octyl L-lactate.
[0176] An exemplary synthetic scheme of making the ester compound ethyl lactate laurate is shown below:
[0177] Q
[0178]
[0179] Scheme 1
[0180] For the synthetic methods described above, conditions (choice of solvcnt(s), temperatures (such as to achieve refluxing), atmospheres, work-up conditions, purification conditions, etc.) can be varied or modified from those discussed and exemplified herein, as appropriate, by the person of ordinary skill in the art of synthetic chemistry, without impacting the synthesis. The methods may include additional steps, which are not otherwise specified, that may be involved in the syntheses which include, but are not limited to, precipitation of a product, washing the reaction mixture, extracting the reaction mixture, separation of the product from a mixture (e.g. by filtration), drying the product, and combinations thereof. Further processing steps that may be involved include stirring, heating and / or cooling the reaction mixture. Intermediate, crude, and purified products can be characterized using any suitable characterization method known to the skilled person. In some instances, such methods include, but are not limited to,
[0181]
[0182] and13C NMR, mass spectrometry, elemental analysis, or other techniques.
[0183] Formulations, such as topical formulations or other particular formulations / compositions, described above, can be prepared by any suitable means known. For example, by mixing one or more ester compounds of Formula I at desired concentrations into one or more suitable carriers or solvents. Additional components, such as excipients, agents (i.e., drug agents), etc. can be included in such mixtures to afford the formulations / compositions having each respective component present at the desired concentration. Mixing of the various components may include optional heating to, for example, promote dissolution of the ester compound(s) and other components / agents, as may be present, in the carriers or solvents.
[0184] In some instances, where the formulation forms an emulsion, such as an inverse emulsion, which involves sonication / shaking and optionally heating may be used to form such emulsions. In some instances, heating is applied to a temperature, such as of at least 24
[0185] 45853111.1about 70 C or higher. Heating may be applied for any suitable amount of time needed to promote formation or increase the rate of formation of self-assembled micelles, such as for a period of time ranging from about 10 to 90 seconds, 20 to 60 seconds, or 30 to 60 seconds, as well as individual values or sub-ranges within the aforementioned ranges. In some instances, sonication can be performed, such as with an ultrasonic probe or by means of an ultrasonic water bath. Sonication can be pulsed with a plurality of pulses having about 3 seconds of sonication time and about 3 seconds of no sonication time per pulse. Other amplitudes and pulse times are possible. For instance, the amplitude can be in a range from about 15 to 50% or 20 to 40% and the pulse time may range from about 1 to 5 seconds or 2 to 4 seconds, as well as individual values or sub-ranges contained within the aforementioned ranges.
[0186] IV. Methods of Using Ester Compounds and Formulations Thereof
[0187] The various compositions including the ester compounds of Formula I can be used for various applications, such as those described below.
[0188] A. Insect Repellent Formulations
[0189] The ester compounds of Formula I and insect repellent formulations thereof disclosed herein can be used to repel arthropods, such as insects. In some instances, the formulations can also repel arachnids. The insect repellent formulations can be used to repel one or more types of insects, such as fleas, ticks, mites, mosquitoes, flies, lice, blowflies, bed bugs, stable flies, horn flies, or black flies, and combinations thereof. Specific examples include, but are not limited to, cat and dog fleas, ticks, and mites, lice (Trichodectes spp., Cheyletiella spp., Linognathus spp., and the like), mosquitoes (Aedes spp., Culex spp., Anopheles spp., Anopheles gambiae, and the like) and flies (Hacmatobia spp., Musca spp., Stomoxys spp., Dermatobia spp., Cochliomyia spp., and the like). In some instances, the arachnid is a spider. In certain instances, the mosquito is a blood- feeding species from any of the known Aedes or Anopheles subspecies, or may be from other species including, without limitation, Culex and Culisela, and their respective subspecies. In some instances, the mosquito is an Aedes aegypti, Anopheles stephensi, or Anopheles gambiae mosquito.
[0190] In one non-limiting instance, a method of repelling an insect or an arachnid, the method includes the steps of:
[0191] (a) applying a topical formulation as disclosed above to at least a portion of a skin surface of a subject;
[0192] 25
[0193] 45853111.1wherein following step (a), the portion of the skin surface to which the topical formulation was applied provides a complete protection time of at least about 9 hours, optionally at least about 10 hours. The topical formulation is an insect repellent formulation.
[0194] For the methods described, the subject can be any mammal. In some instances, the subject is a human. In some instances, the mammal is a livestock or farm animal (such as a cow, horse, etc.) or can be a domesticated animal (such as a dog, cat, etc.). In some instances, the complete protection time (CPT) is provided for at least 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 hours, or longer. In some instances, the complete protection time (CPT) is provided for a period of time ranging from at least about 12 to 24 hours, or individual time values or sub-ranges contained within the aforementioned range. Although there are different criteria used for CPT depending on the organism, for mosquitoes, a non-limiting example of a test to determine CPT using the arm-in-cage testing method. The same method can be used for testing other biting insects, however the time period to determine a confirmed bite may vary, depending on insect of interest. The arm-in-cage method involves step 1 , where a cage containing mosquitoes, such as at a density of about 30 mosquitoes per 30 cubic centimeters; followed by step 2, inserting a forearm, which has exposed skin that has been treated with the repellent formulation to be tested, or is untreated (acting as a control), into the cage for a period of time. Lastly, in step 3 of the method, the complete protection time (CPT) is calculated from the time between repellent application to the exposed skin and insertion into the cage and the first confirmed mosquito bite. A mosquito bite can be confirmed when after the bite occurs a second bite occurs within 30 minutes of the first bite. If a second bite does not occur within 30 minutes of the first bite, the first bite is not a “confirmed mosquito bite” and is dismissed, and the volunteer continues testing. Subsequently, if the volunteer receives another bite at any point of the testing, this subsequent bite is considered the first bite and they leave their arm in the cage for up to at least 30 minutes or until a confirmation bite is recorded (if it occurs in less than 30 minutes) to determine if the subsequent bite is confirmed. The test continues until a set time period is reached without a confirmed bite or until the first confirmed bite is achieved. See, e.g. Luker et al. 2023. Sci Rep 13, 1705.
[0195] In some instances, the repellent formulations demonstrate a Repellency ( / ?%) of at least about 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or up to 100%. In some instances, the repellency ranges from about 25 to 100%, 50 to 100%, or 75 to 100%, or 26
[0196] 45853111.1any individual percentage value or sub-range contained within the aforementioned ranges.
[0197] In some instances, the repellent formulations can be stored inside a container that blocks out or substantially blocks ambient light from reaching the formulation.
[0198] “Substantially blocks,” refers to blocking out at least about 95%, 96%, 97%, 98%, 99%, 99.1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8%, or 99.9% of ambient light present outside of the container.
[0199] B. Topical Personal Care Products
[0200] Methods for using the topical personal care products to treat skin are disclosed herein. In some instances, the method of treating skin, involves
[0201] (a’) applying any one of the topical formulations disclosed herein to at least a portion of a skin surface of a subject. In some instances, the method involves repeating step (a’) at least once a day over a period of time of 1 day, 2 days, 3 day, 4 da s, 5 days, 6 days, 7 days, two, weeks, three weeks, four weeks, one month, two months, three months, four months, five months, or six months.
[0202] In some instances, the hydration and / or moisturization of the skin is improved after a period of time, as compared to the skin prior to step (a’).
[0203] In some instances, the hydration and / or moisturization of the skin is improved by at least about 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%. 45%, 50%. 55%. 60%.
[0204] 65%, 70%, 75%, 80%, 85%, 90%, 95%, 100%, 105%, 110%, 115%, 120%, 125%, 130%, 135%, 140%, 145%, 150%, 155%, 160%, 165%, 170%, 175%, 180%, 185%, 190%, 195%, or 200%; or the hydration and / or moisturization of the skin is improved by an amount ranging from about 1% to 200%.
[0205] C. Pharmaceutical Formulations
[0206] In some other instances, the ester compounds of Formula I, and pharmaceutical formulations thereof, as described herein can be used in methods for enhancing the delivery of a drug agent via skin absorption. In some instances, the method of delivering a drug agent via skin absorption, involves (a”) applying any one of the pharmaceutical formulations disclosed herein to at least a portion of a skin surface of a subject; wherein skin absorption of the at least one drug agent through the skin surface of the subject is enhanced, as compared to skin absorption of the at least one drug agent applied alone to the skin surface.
[0207] 27
[0208] 45853111.1D. Other Formulations and Materials including Ester Compounds Beyond the uses and methods described above, the ester compounds of Formula I can be included in other types of formulations and may form part of materials.
[0209] For example, the ester compounds of Formula I can be included in food-grade formulations, where the ester compound(s) act as a flavoring agent and / or preservative therein.
[0210] In another example, the ester compounds of Formula I can be included in industrial formulations, where the ester compound(s) act as a biodegradable solvent and / or as a lubricant therein. Such formulations may include one or more carriers, such as an oil, and may further include one or more additives selected from the group consisting of corrosion inhibitors, pour point depressants, extreme pressure additives, anti-wear agents, metal deactivators, defoamer additives, penetrating lubricants, detergents, viscosity index improvers, dispersants, tackifiers, emulsifiers, friction modifiers, antioxidants, seal swell agents, or a combination thereof.
[0211] In still another example, the ester compounds of Formula I can be used to make or may form part of a bio-based plastic or resin. In some instance, a reaction product of the ester compound forms or makes part of the plastic or resin, where a reaction product refers to the ester compound being reacted, at least in part, to form the plastic or resin. In some instances, such plastics or resins may further include one or more additives selected from plasticizers, stabilizers, resins, fillers colorants, lubricants, or combinations thereof. Such plastics or resins may be formed by any suitable methods and can be made to have any desired shape or form, for example, by plastic injection molding, rotational molding, extrusion blow molding, injection blow molding, reaction injection molding, vacuum casting, thermoforming, or compression molding.
[0212] The compounds, formulations, and methods herein described are further illustrated in the following examples, which are provided by way of illustration and are not intended to be limiting. It will be appreciated that variations in proportions and alternatives in elements of the components shown will be apparent to those skilled in the art and are within the scope of disclosed forms. All parts or amounts, unless otherwise specified, are by weight.
[0213] The disclosed compounds, emulsions, formulations, as well as methods of using thereof, can be further understood by reference to the following numbered paragraphs:
[0214] 28
[0215] 45853111.1Paragraph 1. An ester compound according to Formula I:
[0216]
[0217] Formula I
[0218] wherein Ri, R2, and R3 are each independently a C1-C30 alkyl group, C2-C30 alkenyl group, or C2-C30 alkynyl group.
[0219] Paragraph 2. The ester compound of paragraph 1, wherein R2 is a Ci alkyl, such as a methyl.
[0220] Paragraph 3. The ester compound of any one of paragraphs 1-2, wherein R3 is a C2 alkyl, such as an ethyl.
[0221] Paragraph 4. The ester compound of any one of paragraphs 1-3, wherein the ester compound has one of the following structures:
[0222]
[0223] 29
[0224] 45853111.1
[0225]
[0226] Paragraph 5. The ester compound of paragraph 1, wherein the ester compound 10 has the following structure:
[0227] 30
[0228] 45853111.1
[0229]
[0230] Paragraph 6. An emulsion comprising:
[0231] (i) one or more cosmetically acceptable carriers; and
[0232] (ii) the ester compound of any one of paragraphs 1 to 5;
[0233] wherein the one or more cosmetically acceptable carriers are optionally impermeable or substantially skin impermeable.
[0234] Paragraph 7. The emulsion of paragraph 6, wherein the one or more cosmetically acceptable carriers are selected from paraffin oil, mineral oil, petroleum, and silicone oil, or a combination thereof.
[0235] Paragraph 8. The emulsion of any one of paragraphs 6-7, wherein the one or more cosmetically acceptable carriers is a base oil, such as a paraffin oil, wherein the paraffin oil is optionally a light paraffin oil, a heavy paraffin oil, or a combination thereof.
[0236] Paragraph 9. The emulsion of any one of paragraphs 6-8, wherein the base oil is at a concentration ranging from about 0.01 wt% to about 95 wt% of the total weight of the skin formulation.
[0237] Paragraph 10. The emulsion of any one of paragraphs 6-9, wherein the ester compound is at a concentration ranging from about 5 wt% to 30 wt% of the total weight of the emulsion or about 5 vol% to 30 vol% of the total volume of the emulsion.
[0238] Paragraph 11. The emulsion of any one of paragraphs 6-10, wherein the emulsion is a microemulsion comprising self-assembled micelles therein.
[0239] Paragraph 12. The emulsion of paragraph 11, wherein the microemulsion is an inverse microemulsion.
[0240] Paragraph 13. The emulsion of any one of paragraphs 6-12, wherein the emulsion is an inverse nanoemulsion.
[0241] Paragraph 14. The emulsion of any one of paragraphs 6-13, wherein the emulsion further comprises one or more surfactants.
[0242] Paragraph 15. The emulsion of any one of paragraphs 6-14, wherein the emulsion is free or substantially free of surfactants.
[0243] Paragraph 16. The emulsion of any one of paragraphs 6-15, wherein the emulsion further comprises (iii) a cargo, wherein the cargo is hydrophilic and is selected 31
[0244] 45853111.1from the group consisting of insect repellent agents, sun blocking agents, antibacterial agents, skin repair agents, wound repair agents, and fragrances, or a combination thereof.
[0245] Paragraph 17. The emulsion of any one of paragraphs 6-16, wherein the emulsion further comprises one or more water-absorbing compounds, optionally selected from the group consisting of carboxymethyl cellulose (CMC), alginate, chitosan, polyacrylates, and combinations thereof.
[0246] Paragraph 18. The emulsion of paragraph 17, wherein the one or more waterabsorbing compounds are present at a concentration ranging from about 0.1 wt% to 5.0 wt%, about 0.1 wt% to 4.5 wt%, about 0.1 wt% to 4.0 wt%, about 0.1 wt% to 3.5 wt%, or about 0.1 wt% to 3.0 wt% of the total weight of the emulsion.
[0247] Paragraph 19. The emulsion of any one of paragraphs 6-18, wherein the emulsion further comprises at least one stabilizer, optionally selected from the group consisting of glycerol oleate, sorbitan oleate, and combinations thereof.
[0248] Paragraph 20. The emulsion of paragraph 19, wherein the at least one stabilizer is present at a concentration ranging from about 0.1 wt% to 5.0 wt%, about 0.1 wt% to 4.5 wt%, about 0.1 wt% to 4.0 wt%, about 0.1 wt% to 3.5 wt%, or about 0.1 wt% to 3.0 wt% of the total weight of the emulsion.
[0249] Paragraph 21. The emulsion of any one of paragraphs 6-20, wherein the emulsion further comprises one or more antioxidants optionally selected from the group consisting of ascorbyl palmitate, tocopherols (vitamin E), butylated hydroxytoluene (BHT), and combinations thereof.
[0250] Paragraph 22. The emulsion of paragraph 21, wherein the one or more antioxidants are present at a concentration ranging from about 0.05 wt% to 3.0 wt%, about 0.05 wt% to 2.5 wt%, about 0.05 wt% to 2.0 wt%, about 0.05 wt% to 1.5 wt%, or about 0.05 wt% to 1.0 wt% of the total weight of the emulsion.
[0251] Paragraph 23. The emulsion of any one of paragraphs 6-22, wherein the emulsion further comprises one or more humectants optionally selected from the group consisting of glycerin, sorbitol, and combinations thereof.
[0252] Paragraph 24. The emulsion of paragraph 23, wherein the one or more humectants are present at a concentration ranging from about 0.5 wt% to 7.0 wt%, about 0.5 wt% to 6.5 wt%, about 0.5 wt% to 6.0 wt%, about 0.5 wt% to 5.5 wt%, about 0.5 wt% to 5.0 wt%, about 0.2 wt% to 5 wt% or about 0.1 wt% to 5 wt% of the total weight of the emulsion.
[0253] 32
[0254] 45853111.1Paragraph 25. The emulsion of any one of paragraphs 6-24, wherein the emulsion is an insect repellent formulation and at least the ester compound provides an insect repellent effect.
[0255] Paragraph 26. The emulsion of any one of paragraphs 6-24, wherein the emulsion is a cosmetic formulation and at least the ester compound acts as an emollient, a moisturizer, and / or a carrier.
[0256] Paragraph 27. The emulsion of any one of paragraphs 6-24, wherein the emulsion is a pharmaceutical formulation further comprising at least one drug agent and at least the ester compound enhances absorption of the at least one drug agent through skin, as compared to a pharmaceutical formulation excluding the ester compound.
[0257] Paragraph 28. The emulsion of any one of paragraphs 6-24, wherein the emulsion is a food-grade, optionally further comprising one or more food-grade acceptable carriers, wherein the ester compound acts as a flavoring agent and / or preservative.
[0258] Paragraph 29. The emulsion of any one of paragraphs 6-24, wherein the emulsion is an industrial formulation, wherein the ester compound acts as a biodegradable solvent and / or as a lubricant.
[0259] Paragraph 30. A topical formulation comprising:
[0260] (i) one or more cosmetically acceptable earners; and
[0261] (ii) the ester compound of any one of paragraphs 1 to 5.
[0262] Paragraph 31. The topical formulation of paragraph 30, wherein the cosmetically acceptable carrier is a base oil that is optionally impermeable or substantially skin impermeable.
[0263] Paragraph 32. The topical formulation of paragraph 31, wherein the base oil is paraffin oil, mineral oil, petroleum, and silicone oil, or a combination thereof.
[0264] Paragraph 33. The topical formulation of any one of paragraphs 31-32, wherein the base oil is paraffin oil, and wherein the paraffin oil is a light paraffin oil, a heavy paraffin oil, or a combination thereof.
[0265] Paragraph 34. The topical formulation of any one of paragraphs 30-33, wherein the ester compound is at a concentration ranging from about 5 wt% to 30 wt% of the total weight of the topical formulation or about 5 vol% to 30 vol% of the total volume of the topical formulation.
[0266] 33
[0267] 45853111.1Paragraph 35. The topical formulation of any one of paragraphs 30-34, wherein the topical formulation further comprises one or more cosmetically acceptable excipients selected from the group consisting of an abrasive, an acidulent, an adhesion promoter, an antioxidant, an antiseptic, an astringent, a barrier agent, a bio-adhesive agent, a botanical agent, a botanical extract, a buffer agent, a bulking agent, a calming agent, a chelating agent, a cleansing agent, an emulsifier agent, a colorant, a conditioning agent, a cooling agent, a deodorant agent, a depilatory agent, a detergent, a disinfectant, a dispersant, an emollient, an emulsifier, an emulsion stabilizer, an essential oil, an exfoliant, a fat soluble agent, a fiber, a film former, a fixative, a foam booster, a foam stabilizer, a foaming agent, a fragrance, a free radical scavenger, a fungicide, a gellant, a glosser, a bleaching agent, a conditioning agent, a humectant, a lathering agent, a lubricant, a make-up agent, a moisture barrier agent, a moisturizing agent, a neutralizer, an odormasking agent, an oil, an oil absorbent agent, an ointment base, an opacifier, an organosilicone, an oxidant, an oxygen carrier, a pearlant agent, a perfume, a perfume solvent, a perfume stabilizer, a peroxide stabilizer, a photo-sensitizer agent, a pigment, a pigmenting agent, a pearlescent aid, a plant extract, a plant derivative, a plant tissue extract, a plant root extract, a plant seed extract, a plant oil, a plasticizer, a polymer, a polymer film former, a preservative agent, a propellant, a reducing agent, a re-fatting agent, a resin, a scalp agent, a scrub agent, a sequestrant, a silicone agent, a skin clarifier, a skin cleanser, a skin lipid, a skin lightening agent, a skin bleaching agent, a solubilizer, a suspending agent, a sun protection agent, a soothing agent, a spreading agent, a stabilizer, a sunless tanning agent, a sunscreen, a sunscreen UVA, a sunscreen UVB, a broad-band sunscreen, a surfactant, an amphoteric surfactant, an anionic surfactant, a cationic surfactant, a non-ionic surfactant, a silicone surfactant, an accelerator, a thickening agent, a thixotrope, a tightening agent, a toner, a tonic agent, a vegetable oil, a volatile agent, a viscosity stabilizer, a vitamin, a water proofing agent, a wax, a wetting agent, a whitening agent, water, water-absorbing agents, dermatologically acceptable organic solvents, and combinations thereof.
[0268] Paragraph 36. The topical formulation of paragraph 35, wherein the one or more cosmetically acceptable excipients is at a concentration ranging from about 0.001 wt% to about 99 wt% of the total weight of the topical formulation.
[0269] 34
[0270] 45853111.1Paragraph 37. The topical formulation of any one of paragraphs 30-36, wherein the cosmetically acceptable carrier is at a concentration ranging from about 0.01 wt% to about 95 wt% of the total weight of the skin formulation.
[0271] Paragraph 38. The topical formulation of any one of paragraphs 30-37, wherein the topical formulation is an insect repellent formulation and at least the ester compound provides an insect repellent effect.
[0272] Paragraph 39. The topical formulation of any one of paragraphs 30-38, further comprising one or more additives optionally selected from the group consisting of insect repellent agents, sun blocking agents, antibacterial agents, skin repair agents, wound repair agents, and fragrances, or a combination thereof.
[0273] Paragraph 40. The topical formulation of paragraph 35, wherein the amphoteric surfactants are imidiazolines and imidiazoline derivatives, isethionates, betaine derivatives, such as cocoamidopropyl betaine, amphoacetate derivatives, propionates, or a combination thereof.
[0274] Paragraph 41. The topical formulation of paragraph 40, wherein the amphoteric surfactant is cocoamidopropyl betaine.
[0275] Paragraph 42. The topical formulation of paragraph 35, wherein the one or more non-ionic surfactants are alcohol ethoxylates, fatty acid ethoxylates, alkyl phenol ethoxylate, monoalkonaolamide ethoxylates, sorbitan esters and their ethoxylated derivatives; such as sorbitan oleate, sorbitan stearate, polysorbate 80 (Polyoxyethylene (80) sorbitan monooleate), polysorbate-20 (polyoxyethylene sorbitan monolaurate), polysorbate-40, (polyoxyethylene sorbitan monopalmitate), polysorbate-60 (polyoxyethylene sorbitan monostearate), and polysorbate-80 (polyoxyethylene sorbitan monooleate); ethoxylated fats and oils, amine ethoxylates, ethylene oxide-propylene oxide co-polymers, glycol esters, glycerol and polyglycerol esters, sucrose esters mono and polysaccharides surfactants, capped alkyl alcohol ethoxylates, fatty alcohol ethoxylate propoxylates, ethoxylated siloxane copolymers, PEG / PPG dimethicones, or a combination thereof.
[0276] Paragraph 43. The topical formulation of paragraph 42, wherein the one or more non-ionic surfactants are polysorbate 20, polysorbate 80, sorbitan oleate, or sorbitan stearate.
[0277] 35
[0278] 45853111.1Paragraph 44. The topical formulation of any one of paragraphs 40-41, wherein the amphoteric surfactants are at a concentration ranging from about 0.1 wt% to about 10 wt% of the total weight of the topical formulation.
[0279] Paragraph 45. The topical formulation of any one of paragraphs 42-43, wherein the non-ionic surfactants are at a concentration ranging from about 0.1 wt% to about 10 wt% of the total weight of the topical formulation.
[0280] Paragraph 46. The topical formulation of paragraph 35, wherein the antioxidants are optionally selected from tocopherol (Vitamin E), ascorbyl palmitate, butylated hydroxytoluene (BHT), and combinations thereof,
[0281] Paragraph 47. The topical formulation of paragraph 46, the antioxidants are at a concentration ranging from about 0.01 wt% to about 5 wt% of the total weight of the topical formulation.
[0282] Paragraph 48. A method of repelling an insect or an arachnid, the method comprising the steps of:
[0283] (a) applying the emulsion of any one of paragraphs 6-29 or the topical formulation of any one of paragraphs 30 to 47 to at least a portion of a skin surface of a subject;
[0284] wherein following step (a), the portion of the skin surface to which the topical formulation was applied provides a complete protection time of at least about 9 hours, optionally at least about 10 hours.
[0285] Paragraph 49. The method of paragraph 48, wherein the insect or arachnid is selected from the group consisting of a mosquito, tick, spider, bed bug, stable fly, horn fly, and black fly, and combinations thereof.
[0286] Paragraph 50. The method of paragraph 49, wherein the mosquito is an Aedes aegypti, Anopheles stephensi, or Anopheles gctmbiae mosquito.
[0287] Paragraph 51. The method of paragraph 48, wherein the subject is a mammal. Paragraph 52. The method of paragraph 51, wherein the subject is a human. Paragraph 53. A cosmetic formulation comprising:
[0288] the ester compound of any one of paragraphs 1 to 5;
[0289] wherein the ester compound acts as an emollient, a moisturizer, and / or a carrier. Paragraph 54. The cosmetic formulation of paragraph 53, wherein the cosmetic formulation is a lotion, a cream, a gel, or an ointment.
[0290] 36
[0291] 45853111.1Paragraph 55. A method of treating skin, the method comprising the steps of: (a’) applying the cosmetic formulation of any one of paragraphs 53 to 54 to at least a portion of a skin surface of a subject.
[0292] Paragraph 56. The method of paragraph 55, further comprising repeating step (a’) at least once a day over a period of time of 1 day, 2 days, 3 days, 4 days, 5 days, 6 days, 7 days, two weeks, three weeks, four weeks, one month, two months, three months, four months, five months, or six months.
[0293] Paragraph 57. The method of any one of paragraphs 55-56, wherein hydration and / or moisturization of the skin is improved after the period of time, as compared to the skin prior to step (a’).
[0294] Paragraph 58. The method of any one of paragraphs 55-57, wherein the hydration and / or moisturization of the skin is improved by at least about 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%. 100%, 105%, 110%, 115%, 120%, 125%, 130%, 135%, 140%, 145%, 150%, 155%, 160%, 165%, 170%, 175%, 180%, 185%, 190%, 195%, or 200%: or wherein the hydration and / or moisturization of the skin is improved by an amount ranging from about 1% to 200%.
[0295] Paragraph 59. A pharmaceutical formulation for delivering a drug agent via skin absorption comprising:
[0296] the ester compound of any one of paragraphs 1 to 5; and
[0297] at least one drag agent;
[0298] optionally further comprising one or more pharmaceutically acceptable excipients and / or carriers:
[0299] wherein the ester compound enhances absorption of the at least one drug agent through skin, as compared to a pharmaceutical formulation excluding the ester compound.
[0300] Paragraph 60. A method of delivering a drag agent via skin absorption, the method comprising the steps of:
[0301] (a”) applying the pharmaceutical formulation of paragraph 59 to at least a portion of a skin surface of a subject;
[0302] wherein skin absorption of the at least one drag agent through the skin surface of the subject is enhanced, as compared to skin absorption of the at least one drug agent when applied alone to the skin surface.
[0303] 37
[0304] 45853111.1Paragraph 61. A food-grade formulation comprising:
[0305] the ester compound of any one of paragraphs 1 to 5; and
[0306] optionally one or more food-grade acceptable carriers;
[0307] wherein the ester compound acts as a flavoring agent and / or preservative.
[0308] Paragraph 62. An industrial formulation comprising:
[0309] the ester compound of any one of paragraphs 1 to 5:
[0310] wherein the ester compound acts as a biodegradable solvent and / or as a lubricant. Paragraph 63. The industrial formulation of paragraph 62, further comprising one or more carriers, such as an oil.
[0311] Paragraph 64. The industrial formulation of any one of paragraphs 62 to 63, further comprising one or more additives selected from the group consisting of corrosion inhibitors, pour point depressants, extreme pressure additives, anti-wear agents, metal deactivators, defoamer additives, penetrating lubricants, detergents, viscosity index improvers, dispersants, tackifiers, emulsifiers, friction modifiers, antioxidants, seal swell agents, or a combination thereof.
[0312] Paragraph 65. A bio-based plastic or resin comprising:
[0313] the ester compound of any one of paragraphs 1 to 5 and / or a reaction product thereof.
[0314] Paragraph 66. The bio-based plastic or resin of paragraph 65, further comprising one or more additives selected from plasticizers, stabilizers, resins, fillers colorants, lubricants, or combinations thereof.
[0315] EXAMPLES
[0316] Example 1: Ethyl Lactate Laurate
[0317] Materials and Methods:
[0318] Synthesis of Ethyl Lactate Laurate:
[0319] Melt lauric acid (10 mmol, 2.00 g) gently at about 45°C. Add EDC (11 mmol, 2.11 g) directly to the melted lauric acid and mix thoroughly. Separately dissolve DMAP (1 mmol, 122 mg) in ethyl lactate (10 mmol, 1.18 g). Within 1-2 minutes, combine the DMAP / ethyl lactate solution with the lauric acid / EDC mixture, and immediately add activated molecular sieves (5 A, 2 g). Stir the reaction mixture at room temperature for 16 hours. After completion, add ethyl lactate (20 mL) to dilute the reaction. Sequentially
[0320] 38
[0321] 45853111.1wash the mixture with water (3 x 20 mL), saturated sodium bicarbonate solution (20 mL), and brine (20 mL). Dry the organic phase over anhydrous sodium sulfate, filter, and concentrate under reduced pressure to yield ethyl lactate laurate as a pale yellow oil (85% purity, yield 2.65 g, 85%). Additional purification by column chromatography provides the product with >95% purity.
[0322] Blood Feeding Assay:
[0323] Aedes aegypti mated females (n = 65 per test cage, 7 days old were placed in a 30 x 30 x 30 cm mesh cage. An artificial membrane feeder (Hemotek, 36 ± 0.5 °C) containing 2 mL defibrinated sheep’s blood was covered with a stretched membrane. The outer face of the membrane was coated with an ethanolic solution containing ethyl lactate laurate to compare formulations contaning different concentrations of ethyl lactate laurate applied onto the membrane based on 5, 10, 15, and 20 vol % ethyl lactate laurate in ethanol. A membrane treated with ethanol alone served as the negative control. Ethanol was allowed to evaporate completely (~5 min) before the feeder was inserted. Mosquitoes were allowed to feed for 20 min in low light. Immediately afterwards, they were cold-anesthetised and scored as engorged (fed) or unfed; % blood-fed = (engorged / 65) x 100. Fig. 1 plots the mean ± SEM of these percent blood-fed values.
[0324] Results:
[0325] Ethyl lactate laurate NMR and MS Results:
[0326] 0.86-0.89 ppm, triplet (J = 7.0 Hz, 3H) - terminal methyl of lauryl chain (CH3-(CFLjio-), 1.23-1.38 ppm, multiplet (16H) - internal methylene protons of the lauryl chain, 1.26 ppm, triplet (J = 7.1 Hz, 3H) - methyl group of ethyl ester (OCH2-CH3), 1.33 ppm, doublet (J = 6.9 Hz, 3H) - methyl of the lactyl fragment (CH3-CH-), 1.59-1.67 ppm, multiplet (2H) - |3-CI I2 adjacent to the ester carbonyl (CH2-CH2-CO), 2.32-2.42 ppm, triplet (J = 7.5 Hz, 2H) - a-CTL next to ester carbonyl (CH2-CO-), 4.17-4.21 ppm, quartet (J = 7.1 Hz, 2H) - methylene of the ethyl ester (O-CH2-CH3), 5.04-5.08 ppm, broad quartet (J = 6.9 Hz, 1H) - methine proton on lactyl backbone (-CH-O-CO-), 7.26 ppm, singlet (1H) - residual CHCL (solvent peak). [M+Na]+for Cn^CLNa, 323.2197 m / z.
[0327] Discussion:
[0328] When ethyl lactate laurate in ethanol was applied to an artificial skin (membrane) different concentrations of 5 vol%, 10 vol%, 15 vol%, and 20 vol% of ethyl lactate laurate were compared against a control formulation (containing no ethyl lactate laurate).
[0329] 39
[0330] 45853111.1It was observed that blood feeding by Aedes aegypti female mosquitoes was notably reduced or essentially eliminated (i.e., providing repellency (7?%) of at least about 90% and up to 100%) by the presence of ethyl lactate laurate on the membrane.
[0331] Concentrations as low as about 10 vol% resulted in essentially no blood feeding observed.
[0332] Ethyl lactate laurate represents an example of a safe, effective, and environmentally friendly insect repellent, and other such functional compounds can be synthesized from other alkyl lactates and fatty acids, as described above. Thus, by leveraging various fatty acids in the esterification process, a wide array of ester compounds can be produced, each with properties suitable for various and specific applications described herein. Ethyl lactate laurate and other such compounds of Formula I can address the limitations of current products like DEET but can also find additional uses, such as in personal care, pharmaceuticals, and industrial applications.
[0333] The disclosed formulations not only meets immediate needs in public health and consumer products. The broad scope of applications and the advantages offered by ethyl lactate laurate and its derivatives position it to be a safe and effective chemical product.
[0334] Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the following claims.
[0335] 40
[0336] 45853111.1
Claims
ClaimsWe claim:
1. An ester compound according to Formula I:OFormula Iwherein Ri, R2, and R3 are each independently a C1-C30 alkyl group, C2-C30 alkenyl group, or C2-C30 alkynyl group.
2. The ester compound of claim 1, wherein R2 is a Ci alkyl, such as a methyl.
3. The ester compound of any one of claims 1-2, wherein R3 is a C2 alkyl, such as an ethyl.
4. The ester compound of any one of claims 1-2, wherein the ester compound has one of the following structures:4145853111.145853111.
15. The ester compound of claim 1, wherein the ester compound has the followingstructure:
6. An emulsion comprising:(i) one or more cosmetically acceptable carriers; and(ii) the ester compound of claim 1 ;wherein the one or more cosmetically acceptable carriers are optionally impermeable or substantially skin impermeable.
7. The emulsion of claim 6, wherein the one or more cosmetically acceptable carriers are selected from paraffin oil, mineral oil, petroleum, and silicone oil, or a combination thereof.
8. The emulsion of any one of claims 6-7. wherein the one or more cosmetically acceptable carriers is a base oil, such as a paraffin oil, wherein the paraffin oil is optionally a light paraffin oil, a heavy paraffin oil, or a combination thereof.
9. The emulsion of any one of claims 6-7, wherein the base oil is at a concentration ranging from about 0.01 wt% to about 95 wt% of the total weight of the skin formulation.4345853111.
110. The emulsion of any one of claims 6-7, wherein the ester compound is at a concentration ranging from about 5 wt% to 30 wt% of the total weight of the emulsion or about 5 vol% to 30 vol% of the total volume of the emulsion.
11. The emulsion of any one of claims 6-7, wherein the emulsion is a microemulsion comprising self-assembled micelles therein.
12. The emulsion of claim 11, wherein the microemulsion is an inverse microemulsion.
13. The emulsion of any one of claims 6-7, wherein the emulsion is an inverse nanoemulsion.
14. The emulsion of any one of claims 6-7, wherein the emulsion further comprises one or more surfactants.
15. The emulsion of any one of claims 6-7, wherein the emulsion is free or substantially free of surfactants.
16. The emulsion of any one of claims 6-7, wherein the emulsion further comprises (iii) a cargo, wherein the cargo is hydrophilic and is selected from the group consisting of insect repellent agents, sun blocking agents, antibacterial agents, skin repair agents, wound repair agents, and fragrances, or a combination thereof.
17. The emulsion of any one of claims 6-7, wherein the emulsion further comprises one or more water-absorbing compounds, optionally selected from the group consisting of carboxymethyl cellulose (CMC), alginate, chitosan, polyacrylates, and combinations thereof.
18. The emulsion of claim 17, wherein the one or more water-absorbing compounds are present at a concentration ranging from about 0.1 wt% to 5.0 wt%, about 0.1 wt% to 4.5 wt%, about 0.1 wt% to 4.0 wt%, about 0.1 wt% to 3.5 wt%, or about 0.1 wt% to 3.0 wt% of the total weight of the emulsion.4445853111.
119. The emulsion of any one of claims 6-7, wherein the emulsion further comprises at least one stabilizer, optionally selected from the group consisting of glycerol oleate, sorbitan oleate, and combinations thereof.
20. The emulsion of claim 19, wherein the at least one stabilizer is present at a concentration ranging from about 0.1 wt% to 5.0 wt%, about 0.1 wt% to 4.5 wt%, about 0.1 wt.% to 4.0 wt.%, about 0.1 wt.% to 3.5 wt.%, or about 0.1 wt% to 3.0 wt% of the total weight of the emulsion.
21. The emulsion of any one of claims 6-7, wherein the emulsion further comprises one or more antioxidants optionally selected from the group consisting of ascorbyl palmitate, tocopherols (vitamin E), butylated hydroxytoluene (BHT), and combinations thereof.
22. The emulsion of claim 21, wherein the one or more antioxidants are present at a concentration ranging from about 0.05 wt% to 3.0 wt%, about 0.05 wt% to 2.5 wt%, about 0.05 wt% to 2.0 wt%, about 0.05 wt% to 1.5 wt%, or about 0.05 wt% to 1.0 wt% of the total weight of the emulsion.
23. The emulsion of any one of claims 6-7, wherein the emulsion further comprises one or more humectants optionally selected from the group consisting of glycerin, sorbitol, and combinations thereof.
24. The emulsion of claim 23, wherein the one or more humectants are present at a concentration ranging from about 0.5 wt% to 7.0 wt%, about 0.5 wt% to 6.5 wt%, about 0.5 wt% to 6.0 wt%, about 0.5 wt% to 5.5 wt%, about 0.5 wt% to 5.0 wt%, about 0.2 wt% to 5 wt% or about 0.1 wt% to 5 wt% of the total weight of the emulsion.
25. The emulsion of any one of claims 6-7, wherein the emulsion is an insect repellent formulation and at least the ester compound provides an insect repellent effect.
26. The emulsion of any one of claims 6-7, wherein the emulsion is a cosmetic formulation and at least the ester compound acts as an emollient, a moisturizer, and / or a carrier.4545853111.
127. The emulsion of any one of claims 6-7, wherein the emulsion is a pharmaceutical formulation further comprising at least one drug agent and at least the ester compound enhances absorption of the at least one drug agent through skin, as compared to a pharmaceutical formulation excluding the ester compound.
28. The emulsion of any one of claims 6-7, wherein the emulsion is a food-grade, optionally further comprising one or more food-grade acceptable carriers, wherein the ester compound acts as a flavoring agent and / or preservative.
29. The emulsion of any one of claims 6-7, wherein the emulsion is an industrial formulation, wherein the ester compound acts as a biodegradable solvent and / or as a lubricant.
30. A topical formulation comprising:(i) one or more cosmetically acceptable carriers; and(ii) the ester compound of claim 1.
31. The topical formulation of claim 30, wherein the cosmetically acceptable carrier is a base oil that is optionally impermeable or substantially skin impermeable.
32. The topical formulation of claim 31, wherein the base oil is paraffin oil, mineral oil, petroleum, and silicone oil, or a combination thereof.
33. The topical formulation of any one of claims 31-32, wherein the base oil is paraffin oil, and wherein the paraffin oil is a light paraffin oil, a heavy paraffin oil, or a combination thereof.
34. The topical formulation of any one of claims 30-32, wherein the ester compound is at a concentration ranging from about 5 wt% to 30 wt% of the total weight of the topical formulation or about 5 vol% to 30 vol% of the total volume of the topical formulation.4645853111.
135. The topical formulation of any one of claims 30-32, wherein the topical formulation further comprises one or more cosmetically acceptable excipients selected from the group consisting of an abrasive, an acidulent, an adhesion promoter, an antioxidant, an antiseptic, an astringent, a barrier agent, a bio-adhesive agent, a botanical agent, a botanical extract, a buffer agent, a bulking agent, a calming agent, a chelating agent, a cleansing agent, an emulsifier agent, a colorant, a conditioning agent, a cooling agent, a deodorant agent, a depilatory agent, a detergent, a disinfectant, a dispersant, an emollient, an emulsifier, an emulsion stabilizer, an essential oil, an exfoliant, a fat soluble agent, a fiber, a film former, a fixative, a foam booster, a foam stabilizer, a foaming agent, a fragrance, a free radical scavenger, a fungicide, a gellant, a glosser, a bleaching agent, a conditioning agent, a humectant, a lathering agent, a lubricant, a make-up agent, a moisture barrier agent, a moisturizing agent, a neutralizer, an odor-masking agent, an oil, an oil absorbent agent, an ointment base, an opacifier, an organosilicone, an oxidant, an oxygen carrier, a pearlant agent, a perfume, a perfume solvent, a perfume stabilizer, a peroxide stabilizer, a photosensitizer agent, a pigment, a pigmenting agent, a pearlescent aid, a plant extract, a plant derivative, a plant tissue extract, a plant root extract, a plant seed extract, a plant oil, a plasticizer, a polymer, a polymer film former, a preservative agent, a propellant, a reducing agent, a re-fatting agent, a resin, a scalp agent, a scrub agent, a sequestrant, a silicone agent, a skin clarifier, a skin cleanser, a skin lipid, a skin lightening agent, a skin bleaching agent, a solubilizer, a suspending agent, a sun protection agent, a soothing agent, a spreading agent, a stabilizer, a sunless tanning agent, a sunscreen, a sunscreen UVA, a sunscreen UVB, a broadband sunscreen, a surfactant, an amphoteric surfactant, an anionic surfactant, a cationic surfactant, a non-ionic surfactant, a silicone surfactant, an accelerator, a thickening agent, a thixotrope, a tightening agent, a toner, a tonic agent, a vegetable oil, a volatile agent, a viscosity stabilizer, a vitamin, a water proofing agent, a wax, a wetting agent, a whitening agent, water, water-absorbing agents, dermatologically acceptable organic solvents, and combinations thereof.
36. The topical formulation of claim 35, wherein the one or more cosmetically acceptable excipients is at a concentration ranging from about 0.001 wt% to about 99 wt% of the total weight of the topical formulation.4745853111.
137. The topical formulation of any one of claims 30-32, wherein the cosmetically acceptable carrier is at a concentration ranging from about 0.01 wt% to about 95 wt% of the total weight of the skin formulation.
38. The topical formulation of any one of claims 30-32, wherein the topical formulation is an insect repellent formulation and at least the ester compound provides an insect repellent effect.
39. The topical formulation of any one of claims 30-32, further comprising one or more additives optionally selected from the group consisting of insect repellent agents, sun blocking agents, antibacterial agents, skin repair agents, wound repair agents, and fragrances, or a combination thereof.
40. The topical formulation of claim 35, wherein the amphoteric surfactants are imidiazolines and imidiazoline derivatives, isethionates, betaine derivatives, such as cocoamidopropyl betaine, amphoacetate derivatives, propionates, or a combination thereof.
41. The topical formulation of claim 40, wherein the amphoteric surfactant is cocoamidopropyl betaine.
42. The topical formulation of claim 35, wherein the one or more non-ionic surfactants are alcohol ethoxylates, fatty acid ethoxylates, alkyl phenol ethoxylate, monoalkonaolamide ethoxylates, sorbitan esters and their ethoxylated derivatives; such as sorbitan oleate, sorbitan stearate, polysorbate 80 (Polyoxyethylene (80) sorbitan monooleate), polysorbate-20 (polyoxyethylene sorbitan monolaurate), polysorbate-40, (polyoxyethylene sorbitan monopalmitate), polysorbate-60 (polyoxyethylene sorbitan monostearate), and polysorbate-80 (polyoxyethylene sorbitan monooleate); ethoxylated fats and oils, amine ethoxylates, ethylene oxide-propylene oxide co-polymers, glycol esters, glycerol and polyglycerol esters, sucrose esters mono and polysaccharides surfactants, capped alkyl alcohol ethoxylates, fatty alcohol ethoxylate propoxylates, ethoxylated siloxane copolymers, PEG / PPG dimethicones, or a combination thereof.4845853111.
143. The topical formulation of claim 42, wherein the one or more non-ionic surfactants are polysorbate 20, polysorbate 80, sorbitan oleate, or sorbitan stearate.
44. The topical formulation of claim 40, wherein the amphoteric surfactants are at a concentration ranging from about 0.1 wt% to about 10 wt% of the total weight of the topical formulation.
45. The topical formulation of claim 42, wherein the non-ionic surfactants are at a concentration ranging from about 0.1 wt% to about 10 wt% of the total weight of the topical formulation.
46. The topical formulation of claim 35, wherein the antioxidants are optionally selected from tocopherol (Vitamin E), ascorbyl palmitate, butylated hydroxytoluene (BHT), and combinations thereof,47. The topical formulation of claim 46, the antioxidants are at a concentration ranging from about 0.01 wt% to about 5 wt% of the total weight of the topical formulation.
48. A method of repelling an insect or an arachnid, the method comprising the steps of:(a) applying the emulsion of any one of claims 6-7 or the topical formulation of any one of claims 30 to 32 to at least a portion of a skin surface of a subject;wherein following step (a), the portion of the skin surface to which the topical formulation was applied provides a complete protection time of at least about 9 hours, optionally at least about 10 hours.
49. The method of claim 48, wherein the insect or arachnid is selected from the group consisting of a mosquito, tick, spider, bed bug, stable fly, horn fly, and black fly, and combinations thereof.
50. The method of claim 49, wherein the mosquito is an Aedes aegypti, Anopheles stephensi, or Anopheles gambiae mosquito.
51. The method of claim 48, wherein the subject is a mammal.4945853111.
152. The method of claim 51, wherein the subject is a human.
53. A cosmetic formulation comprising:the ester compound of claim 1 ;wherein the ester compound acts as an emollient, a moisturizer, and / or a carrier.
54. The cosmetic formulation of claim 53, wherein the cosmetic formulation is a lotion, a cream, a gel, or an ointment.
55. A method of treating skin, the method comprising the steps of:(a’) applying the cosmetic formulation of any one of claims 53 to 54 to at least a portion of a skin surface of a subject.
56. The method of claim 55, further comprising repeating step (a’) at least once a day over a period of time of 1 day, 2 days, 3 days, 4 days, 5 days, 6 days, 7 days, two weeks, three weeks, four weeks, one month, two months, three months, four months, five months, or six months.
57. The method of any one of claims 55-56, wherein hydration and / or moisturization of the skin is improved after the period of time, as compared to the skin prior to step (a’).
58. The method of any one of claims 55-56, wherein the hydration and / or moisturization of the skin is improved by at least about 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 100%, 105%, 110%, 115%, 120%, 125%, 130%, 135%, 140%, 145%, 150%, 155%, 160%, 165%, 170%, 175%, 180%, 185%, 190%, 195%, or 200%; or wherein the hydration and / or moisturization of the skin is improved by an amount ranging from about 1% to 200%.
59. A pharmaceutical formulation for delivering a drug agent via skin absorption comprising:the ester compound of claim 1 ; andat least one drug agent;5045853111.1optionally further comprising one or more pharmaceutically acceptable excipients and / or carriers;wherein the ester compound enhances absorption of the at least one drug agent through skin, as compared to a pharmaceutical formulation excluding the ester compound.
60. A method of delivering a drug agent via skin absorption, the method comprising the steps of:(a”) applying the pharmaceutical formulation of claim 59 to at least a portion of a skin surface of a subject;wherein skin absorption of the at least one drug agent through the skin surface of the subject is enhanced, as compared to skin absorption of the at least one drug agent when applied alone to the skin surface.
61. A food-grade formulation comprising :the ester compound of claim 1 ; andoptionally one or more food-grade acceptable carriers;wherein the ester compound acts as a flavoring agent and / or preservative.
62. An industrial formulation comprising:the ester compound of claim 1 ;wherein the ester compound acts as a biodegradable solvent and / or as a lubricant.
63. The industrial formulation of claim 62, further comprising one or more carriers, such as an oil.
64. The industrial formulation of any one of claims 62 to 63, further comprising one or more additives selected from the group consisting of corrosion inhibitors, pour point depressants, extreme pressure additives, anti-wear agents, metal deactivators, defoamer additives, penetrating lubricants, detergents, viscosity index improvers, dispersants, tackifiers, emulsifiers, friction modifiers, antioxidants, seal swell agents, or a combination thereof.5145853111.
165. A bio-based plastic or resin comprising:the ester compound of claim 1 and / or a reaction product thereof.
66. The bio-based plastic or resin of claim 65, further comprising one or more additives selected from plasticizers, stabilizers, resins, fillers colorants, lubricants, or combinations thereof.5245853111.1
